142 related articles for article (PubMed ID: 8592143)
1. Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells.
Prasanna P; Thibault A; Liu L; Samid D
J Neurochem; 1996 Feb; 66(2):710-6. PubMed ID: 8592143
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.
Melichar B; Ferrandina G; Verschraegen CF; Loercher A; Abbruzzese JL; Freedman RS
Clin Cancer Res; 1998 Dec; 4(12):3069-76. PubMed ID: 9865922
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin and phenylacetate induce apoptosis, but not differentiation, in human malignant glioma cells.
Schmidt F; Groscurth P; Kermer M; Dichgans J; Weller M
Acta Neuropathol; 2001 Mar; 101(3):217-24. PubMed ID: 11307620
[TBL] [Abstract][Full Text] [Related]
4. Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.
Samid D; Ram Z; Hudgins WR; Shack S; Liu L; Walbridge S; Oldfield EH; Myers CE
Cancer Res; 1994 Feb; 54(4):891-5. PubMed ID: 8313377
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy.
Singh I; Pahan K; Khan M
FEBS Lett; 1998 Apr; 426(3):342-6. PubMed ID: 9600263
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages.
Pahan K; Sheikh FG; Namboodiri AM; Singh I
J Clin Invest; 1997 Dec; 100(11):2671-9. PubMed ID: 9389730
[TBL] [Abstract][Full Text] [Related]
7. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
Adam L; Crépin M; Isräel L
Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
[TBL] [Abstract][Full Text] [Related]
8. Phenylacetate inhibits isoprenoid biosynthesis and suppresses growth of human pancreatic carcinoma.
Harrison LE; Wojciechowicz DC; Brennan MF; Paty PB
Surgery; 1998 Sep; 124(3):541-50. PubMed ID: 9736908
[TBL] [Abstract][Full Text] [Related]
9. Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.
Dimitroulakos J; Lorimer IA; Goss G
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4426s-4431s. PubMed ID: 16857822
[TBL] [Abstract][Full Text] [Related]
10. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.
Crick DC; Andres DA; Danesi R; Macchia M; Waechter CJ
J Neurochem; 1998 Jun; 70(6):2397-405. PubMed ID: 9603204
[TBL] [Abstract][Full Text] [Related]
11. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
12. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability.
Repko EM; Maltese WA
J Biol Chem; 1989 Jun; 264(17):9945-52. PubMed ID: 2722887
[TBL] [Abstract][Full Text] [Related]
13. Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells.
Jones KD; Couldwell WT; Hinton DR; Su Y; He S; Anker L; Law RE
Biochem Biophys Res Commun; 1994 Dec; 205(3):1681-7. PubMed ID: 7811252
[TBL] [Abstract][Full Text] [Related]
14. Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines.
Mikulski SM; Viera A; Darzynkiewicz Z; Shogen K
Br J Cancer; 1992 Aug; 66(2):304-10. PubMed ID: 1503903
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
16. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
17. Effects of Lovastatin on Brain Cancer Cells.
Amadasu E; Kang R; Usmani A; Borlongan CV
Cell Transplant; 2022; 31():9636897221102903. PubMed ID: 35670207
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.
Raiteri M; Arnaboldi L; McGeady P; Gelb MH; Verri D; Tagliabue C; Quarato P; Ferraboschi P; Santaniello E; Paoletti R; Fumagalli R; Corsini A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1144-53. PubMed ID: 9190847
[TBL] [Abstract][Full Text] [Related]
20. Sodium phenylacetate (NaPa) improves the TAM effect on glioblastoma experimental tumors by inducing cell growth arrest and apoptosis.
Wei MX; Liu JM; Gadal F; Yi P; Liu J; Crepin M
Anticancer Res; 2007; 27(2):953-8. PubMed ID: 17465226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
